Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof

Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof

US Patent 11180478 · Granted Nov 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protein degradation agent compound preparation method and application2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025